Researchers have shown a new drug compound can prevent long COVID symptoms in mice—a landmark finding that could lead to a ...

NIH cuts target $1.6 billion RECOVER initiative to study and improve treatment of long COVID, putting further research gains ...

Rutgers Health researchers have developed an oral antiviral drug candidate for COVID-19 that could overcome major limitations ...

“We’re hopeful that some of these compounds that have never been tested before against coronavirus may lead to a potential treatment down the road,” Frantz said. “It could be an alternative or backup ...

The drug is thought to have anti-inflammatory and pain-relieving properties, and is used off-label in people with fibromyalgia and ME/CFS, so it carries potential as a long Covid treatment ...

the best forms of treatment and what puts someone at risk for long COVID. MORE: 5 years ago, the WHO declared COVID a pandemic. Here's a look at the disease by the numbers There are still many ...

Ensitrelvir, an oral SARS-CoV-2 3CL protease inhibitor, is approved in Japan for the treatment of mild-to-moderate COVID-19, wrote Akimasa Fukushi, MD, of Shionogi & Co., Ltd, the drug’s ...